Niner Pharmaceuticals Expands Into High-Purity Peptide Segment for Metabolic Health; Announces R&D for AI-Driven Ambientera Solution
Hyderabad – January 19, 2025 – Niner Pharmaceuticals LLC has announced a major strategic expansion into the global high-purity peptide segment, shifting its focus beyond...

